The combined effect of metformin and mirabegron on diet‐induced obesity

The combined effect of metformin and mirabegron on diet‐induced obesity

Abstract Anti‐obesity medications act by suppressing energy intake (EI), promoting energy expenditure (EE), or both. Metformin (Met) and mirabegron (Mir) cause weight loss by targeting EI and EE, respectively. However, anti‐obesity effects during concurrent use of both have yet to be explored. In th...

Full description

Bibliographic Details
Main Authors: Xin‐Yuan Zhao, Ying Liu, Xuan Zhang, Ben‐Chi Zhao, George Burley, Zhi‐Can Yang, Yi Luo, An‐Qi Li, Ruo‐Xin Zhang, Zhi‐Ying Liu, Yan‐Chuan Shi, Qiao‐Ping Wang
Format: Article
Language:English
Published: Wiley 2023-04-01
Series:MedComm
Subjects:
β3‐adrenergic receptor agonist
combination therapy for obesity
energy expenditure
food intake
metformin
thermogenesis
Online Access:https://doi.org/10.1002/mco2.207

Similar Items

Similar Items